SNY vs. NVO
Compare and contrast key facts about Sanofi (SNY) and Novo Nordisk A/S (NVO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SNY or NVO.
Correlation
The correlation between SNY and NVO is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
SNY vs. NVO - Performance Comparison
Key characteristics
SNY:
-0.07
NVO:
-0.43
SNY:
0.06
NVO:
-0.37
SNY:
1.01
NVO:
0.95
SNY:
-0.07
NVO:
-0.36
SNY:
-0.18
NVO:
-1.15
SNY:
8.86%
NVO:
13.25%
SNY:
22.20%
NVO:
35.35%
SNY:
-46.65%
NVO:
-71.30%
SNY:
-18.91%
NVO:
-41.92%
Fundamentals
SNY:
$122.70B
NVO:
$486.49B
SNY:
$1.89
NVO:
$2.99
SNY:
25.89
NVO:
36.12
SNY:
0.76
NVO:
1.61
SNY:
$59.54B
NVO:
$270.58B
SNY:
$40.42B
NVO:
$229.07B
SNY:
$11.26B
NVO:
$135.97B
Returns By Period
In the year-to-date period, SNY achieves a -4.56% return, which is significantly higher than NVO's -16.93% return. Over the past 10 years, SNY has underperformed NVO with an annualized return of 3.87%, while NVO has yielded a comparatively higher 17.16% annualized return.
SNY
-4.56%
-1.13%
1.30%
-1.56%
1.77%
3.87%
NVO
-16.93%
-19.26%
-39.90%
-16.95%
26.03%
17.16%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SNY vs. NVO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Sanofi (SNY) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SNY vs. NVO - Dividend Comparison
SNY's dividend yield for the trailing twelve months is around 4.29%, more than NVO's 1.70% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SNY Sanofi | 4.29% | 3.83% | 4.22% | 3.80% | 3.61% | 3.46% | 4.29% | 3.67% | 4.03% | 3.79% | 4.19% | 3.47% |
NVO Novo Nordisk A/S | 1.70% | 0.99% | 1.18% | 1.34% | 1.86% | 2.12% | 2.47% | 2.12% | 3.93% | 1.31% | 1.96% | 1.72% |
Drawdowns
SNY vs. NVO - Drawdown Comparison
The maximum SNY drawdown since its inception was -46.65%, smaller than the maximum NVO drawdown of -71.30%. Use the drawdown chart below to compare losses from any high point for SNY and NVO. For additional features, visit the drawdowns tool.
Volatility
SNY vs. NVO - Volatility Comparison
The current volatility for Sanofi (SNY) is 8.69%, while Novo Nordisk A/S (NVO) has a volatility of 20.84%. This indicates that SNY experiences smaller price fluctuations and is considered to be less risky than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
SNY vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Sanofi and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities